Orasis Pharmaceuticals

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

VisusNano

This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.

Kedalion Therapeutics

This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.

Graybug Vision

The company develops sustained-release injectable medicines for patients with retinal diseases and glaucoma to reduce the frequency of ocular treatments.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

VISUfarma

This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.

Envisia

This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.

Glassless

This company develops software that adjusts mobile screen displays to match individual visual profiles, allowing users with presbyopia to read without glasses.